Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Noxopharm Announces Veyonda Awarded First Allowed Patent Application (ASX:NOX)

Noxopharm (NOX:ASX) announces that Australian patent application No. 2016401508 has been allowed by the Australian Patent Office. The patent claims are directed to a suppository formulation includin...read more

Update on Progress in Nyrada Programs (ASX:NYR)

Highlights: Two lead R&D programs progressing as planned and on-budget Brain injury program leads to discovery of a new generation of more potent drug candidates PCSK9 (cholesterol-lowerin...read more

Response to ASX Aware Query (ASX:NET)

For the full response, please download the attached PDF

Novatti Group Announces NOV and RNT Sign Formal Partnering Agreements (ASX:NOV)

Novatti Group Limited (ASX:NOV) (Novatti or ‘the Company’), a leading digital banking and payments company, has finalised its new partnership with Rent.com.au (ASX:RNT) to redevelop its ...read more

Novatti Group - RNT and NOV Sign Formal Partnering Agreements (ASX:NOV)

Rent.com.au Limited (ASX: RNT) (“Rent.com.au” or “the Company”), is pleased to announce that it has signed formal agreements to partner with Novatti Group Limited (ASX:NOV) (...read more

Noxopharm announces LuPIN Prostate Cancer Trial Fully Recruited (ASX:NOX)

Noxopharm (ASX: NOX) advises that the last patient has been enrolled and safely dosed in the ongoing LuPIN Phase I/II clinical trial being conducted by St Vincent’s Hospital Sydney. This compl...read more

NetLinkz - Half Year Accounts (ASX:NET)

To view the statement of financial performance, download the attached PDF.

December 2019 Half Year Commentary (ASX:NOV)

Highlights: Transaction processing revenue of over $1.5M in the December quarter Improvement of Normalised EBITDA from ($1,552,538) to ($1,162,628) compared to the corresponding half-year Tran...read more

Appendix 4D and Half Year Financial Statements (ASX:NOV)

For the full report, please download the attached PDF

iLinkAll signs RMB 1m contract with Pinnacle (Shanghai) Info (ASX:NET)

iLinkAll signs RMB 1m contract with Pinnacle (Shanghai) Information Consultation Ltd to act as agent for VSN (Virtual Security Network), iLinkAll’s intelligent network security product For ...read more

Pause in Trading (ASX:NET)

Trading in the securities of the entity will be temporarily paused pending a further announcement. Please download the attached PDF

Noxopharm announces FDA grants IND approval to Veyonda (ASX:NOX)

Noxopharm (NOX:ASX) announces today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for Veyonda® for combination treatment with doxor...read more

NetLinkz - Replacement Appendix 2A (ASX:NET)

NetLinkz Limited (ASX: NET) ('NetLinkz' or 'Company') advises that the Appendix 2A released today 20 February 2020 overstated the amount of quoted shares issued (page 13 Point 5 &nda...read more

NetLinkz - Issue of unlisted Options (ASX:NET)

Netlinkz Limited (“the Company”) (ASX: NET) notifies the issue of 1,125,000 Unlisted Options (exercisable at $0.13 on or before 18 February 2023) in the Company to EverBlu Capital Pty Lt...read more

NetLinkz - Disclosure Document - S708A Cleansing Statement (ASX:NET)

This notice is given by Netlinkz Limited (“the Company”) (ASX: NET) under section 708A (5)(e) of the Corporations Act 2001 (Cth) (the “Corporations Act”) in relation to the f...read more

Viewing: 1 - 15 of 200 Previous | Next